![Characterizing the Binding Interactions between DNA-Binding Proteins, XPA and XPE: A Molecular Dynamics Approach | ACS Omega Characterizing the Binding Interactions between DNA-Binding Proteins, XPA and XPE: A Molecular Dynamics Approach | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.8b01793/asset/images/medium/ao-2018-017938_0008.gif)
Characterizing the Binding Interactions between DNA-Binding Proteins, XPA and XPE: A Molecular Dynamics Approach | ACS Omega
![PDZ domains and their binding partners: structure, specificity, and modification | Cell Communication and Signaling | Full Text PDZ domains and their binding partners: structure, specificity, and modification | Cell Communication and Signaling | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1478-811X-8-8/MediaObjects/12964_2009_Article_191_Fig1_HTML.jpg)
PDZ domains and their binding partners: structure, specificity, and modification | Cell Communication and Signaling | Full Text
![Structure-function analysis of the DNA-binding domain of a transmembrane transcriptional activator | Scientific Reports Structure-function analysis of the DNA-binding domain of a transmembrane transcriptional activator | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-01031-9/MediaObjects/41598_2017_1031_Fig1_HTML.jpg)
Structure-function analysis of the DNA-binding domain of a transmembrane transcriptional activator | Scientific Reports
![A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity: Molecular Therapy - Oncolytics A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/3782ca85-803b-48d7-adae-3ab24294d60e/fx1_lrg.jpg)
A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity: Molecular Therapy - Oncolytics
![Frontiers | Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions Frontiers | Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions](https://www.frontiersin.org/files/Articles/830202/fviro-02-830202-HTML/image_m/fviro-02-830202-g001.jpg)
Frontiers | Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates | ACS Nano
![In Silico Prediction of Compounds Binding to Human Plasma Proteins by QSAR Models - Sun - 2018 - ChemMedChem - Wiley Online Library In Silico Prediction of Compounds Binding to Human Plasma Proteins by QSAR Models - Sun - 2018 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/0f904b71-8bb4-43ba-b362-747cf89e718b/cmdc201700582-toc-0001-m.jpg)
In Silico Prediction of Compounds Binding to Human Plasma Proteins by QSAR Models - Sun - 2018 - ChemMedChem - Wiley Online Library
![68Ga]ABY-028: an albumin-binding domain (ABD) protein-based imaging tracer for positron emission tomography (PET) studies of altered vascular permeability and predictions of albumin-drug conjugate transport | EJNMMI Research | Full Text 68Ga]ABY-028: an albumin-binding domain (ABD) protein-based imaging tracer for positron emission tomography (PET) studies of altered vascular permeability and predictions of albumin-drug conjugate transport | EJNMMI Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13550-020-00694-2/MediaObjects/13550_2020_694_Fig1_HTML.png)
68Ga]ABY-028: an albumin-binding domain (ABD) protein-based imaging tracer for positron emission tomography (PET) studies of altered vascular permeability and predictions of albumin-drug conjugate transport | EJNMMI Research | Full Text
Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection - Chemical Communications (RSC Publishing)
The Modular Organization of Domain Structures: Insights into Protein–Protein Binding | PLOS Computational Biology
Insights into Protein–DNA Interactions through Structure Network Analysis | PLOS Computational Biology
![Staphylococcal protein A inhibits complement activation by interfering with IgG hexamer formation | PNAS Staphylococcal protein A inhibits complement activation by interfering with IgG hexamer formation | PNAS](https://www.pnas.org/cms/10.1073/pnas.2016772118/asset/47f6f0c8-66db-4595-be4f-2ab5f0d4b9fe/assets/images/large/pnas.2016772118fig01.jpg)
Staphylococcal protein A inhibits complement activation by interfering with IgG hexamer formation | PNAS
![Viruses | Free Full-Text | Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein Viruses | Free Full-Text | Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein](https://www.mdpi.com/viruses/viruses-13-01974/article_deploy/html/images/viruses-13-01974-g001.png)